Patient gender as a factor associated with lymph node metastasis in T1 colorectal cancer: A systematic review and meta-analysis
- Authors:
- Katsuro Ichimasa
- Shin‑Ei Kudo
- Hideyuki Miyachi
- Yuta Kouyama
- Fumio Ishida
- Toshiyuki Baba
- Atsushi Katagiri
- Kunihiko Wakamura
- Takemasa Hayashi
- Tomokazu Hisayuki
- Toyoki Kudo
- Masashi Misawa
- Yuichi Mori
- Shingo Matsudaira
- Yui Kimura
- Yuki Kataoka
-
Affiliations: Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Kanagawa 224‑8503, Japan, Hospital Care Research Unit, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo 660‑8550, Japan - Published online on: February 22, 2017 https://doi.org/10.3892/mco.2017.1172
- Pages: 517-524
This article is mentioned in:
Abstract
Lee EJ, Lee JB, Lee SH and Youk EG: Endoscopic treatment of large colorectal tumors: Comparison of endoscopic mucosal resection, endoscopic mucosal resection-precutting and endoscopic submucosal dissection. Surg Endosc. 26:2220–2230. 2012. View Article : Google Scholar : PubMed/NCBI | |
Tanaka S, Oka S, Kaneko I, Hirata M, Mouri R, Kanao H, Yoshida S and Chayama K: Endoscopic submucosal dissection for colorectal neoplasia: Possibility of standardization. Gastrointest Endosc. 66:100–107. 2007. View Article : Google Scholar : PubMed/NCBI | |
Kobayashi N, Saito Y, Uraoka T, Matsuda T, Suzuki H and Fujii T: Treatment strategy for laterally spreading tumors in Japan: Before and after the introduction of endoscopic submucosal dissection. J Gastroenterol Hepatol. 24:1387–1392. 2009. View Article : Google Scholar : PubMed/NCBI | |
Miyachi H, Kudo SE, Ichimasa K, Hisayuki T, Oikawa H, Matsudaira S, Kouyama Y, Kimura YJ, Misawa M, Mori Y, et al: Management of T1 colorectal cancers after endoscopic treatment based on the risk stratification of lymph node metastasis. J Gastroenterol Hepatol. 31:1126–1132. 2016. View Article : Google Scholar : PubMed/NCBI | |
Kobayashi H, Mochizuki H, Morita T, Kotake K, Teramoto T, Kameoka S, Saito Y, Takahashi K, Hase K, Oya M, et al: Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study. J Gastroenterol. 46:203–211. 2011. View Article : Google Scholar : PubMed/NCBI | |
Son HJ, Song SY, Lee WY, Yang SS, Park SH, Yang MH, Yoon SH and Chun HK: Characteristics of early colorectal carcinoma with lymph node metastatic disease. Hepatogastroenterology. 55:1293–1297. 2008.PubMed/NCBI | |
Hackelsberger A, Fruhmorgen P, Weiler H, Heller T, Seeliger H and Junghanns K: Endoscopic polypectomy and management of colorectal adenomas with invasive carcinoma. Endoscopy. 27:153–158. 1995. View Article : Google Scholar : PubMed/NCBI | |
AB III Benson, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, et al: Localized colon cancer, version 3.2013: Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 11:519–528. 2013.PubMed/NCBI | |
Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandalà M, Cervantes A and Arnold D; ESMO Guidelines Working Group, : Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 24 Suppl 6:vi64–vi72. 2013. View Article : Google Scholar : PubMed/NCBI | |
Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, et al: Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 20:207–239. 2015. View Article : Google Scholar : PubMed/NCBI | |
Nakadoi K, Oka S, Tanaka S, Hayashi N, Terasaki M, Arihiro K, Shimamoto F and Chayama K: Condition of muscularis mucosae is a risk factor for lymph node metastasis in T1 colorectal carcinoma. Surg Endosc. 28:1269–1276. 2014. View Article : Google Scholar : PubMed/NCBI | |
Kitajima K, Fujimori T, Fujii S, Takeda J, Ohkura Y, Kawamata H, Kumamoto T, Ishiguro S, Kato Y, Shimoda T, et al: Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: A Japanese collaborative study. J Gastroenterol. 39:534–543. 2004. View Article : Google Scholar : PubMed/NCBI | |
Wada H, Shiozawa M, Katayama K, Okamoto N, Miyagi Y, Rino Y, Masuda M and Akaike M: Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer. J Gastroenterol. 50:727–734. 2015. View Article : Google Scholar : PubMed/NCBI | |
Choi JY, Jung SA, Shim KN, Cho WY, Keum B, Byeon JS, Huh KC, Jang BI, Chang DK, Jung HY, et al: Meta-analysis of predictive clinicopathologic factors for lymph node metastasis in patients with early colorectal carcinoma. J Korean Med Sci. 30:398–406. 2015. View Article : Google Scholar : PubMed/NCBI | |
Beaton C, Twine CP, Williams GL and Radcliffe AG: Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer. Colorectal Dis. 15:788–797. 2013. View Article : Google Scholar : PubMed/NCBI | |
Bosch SL, Teerenstra S, de Wilt JH, Cunningham C and Nagtegaal ID: Predicting lymph node metastasis in pT1 colorectal cancer: A systematic review of risk factors providing rationale for therapy decisions. Endoscopy. 45:827–834. 2013. View Article : Google Scholar : PubMed/NCBI | |
Mou S, Soetikno R, Shimoda T, Rouse R and Kaltenbach T: Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: A systematic review and meta-analysis. Surg Endosc. 27:2692–2703. 2013. View Article : Google Scholar : PubMed/NCBI | |
Moher D, Liberati A, Tetzlaff J and Altman DG; PRISMA Group, : Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 6:e10000972009. View Article : Google Scholar : PubMed/NCBI | |
Higgins J and Green S: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. 2008. The Cochrane Collaboration; 2011 | |
Hayden JA, van der Windt DA, Cartwright JL, Côté P and Bombardier C: Assessing bias in studies of prognostic factors. Ann Intern Med. 158:280–286. 2013. View Article : Google Scholar : PubMed/NCBI | |
Iorio A, Spencer FA, Falavigna M, Alba C, Lang E, Burnand B, McGinn T, Hayden J, Williams K, Shea B, et al: Use of GRADE for assessment of evidence about prognosis: Rating confidence in estimates of event rates in broad categories of patients. BMJ. 350:h8702015. View Article : Google Scholar : PubMed/NCBI | |
Umemura K, Takagi S, Shimada T, Masuda T, Shiga H, Takahashi S, Takahashi S, Kinouchi Y, Shibuya D and Shimosegawa T: Prognostic and diagnostic significance of tumor budding associated with β-catenin expression in submucosal invasive colorectal carcinoma. Tohoku J Exp Med. 229:53–59. 2013. View Article : Google Scholar : PubMed/NCBI | |
Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, Saito Y, Watanabe M, Morita T, Hida J, et al: Is total mesorectal excision always necessary for T1-T2 lower rectal cancer? Ann Surg Oncol. 17:973–980. 2010. View Article : Google Scholar : PubMed/NCBI | |
Yamamoto S, Watanabe M, Hasegawa H, Baba H, Yoshinare K, Shiraishi J and Kitajima M: The risk of lymph node metastasis in T1 colorectal carcinoma. Hepatogastroenterology. 51:998–1000. 2004.PubMed/NCBI | |
Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC and Altman DG: Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. J Am Med Assoc. 291:2457–2465. 2004. View Article : Google Scholar | |
Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T and Uchida Y: Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum. 38:1286–1295. 1995. View Article : Google Scholar : PubMed/NCBI | |
Arai T, Akiyama Y, Yamamura A, Hosoi T, Shibata T, Saitoh K, Okabe S and Yuasa Y: Allelotype analysis of early colorectal cancers with lymph node metastasis. Int J Cancer. 79:418–423. 1998. View Article : Google Scholar : PubMed/NCBI | |
Bayar S, Saxena R, Emir B and Salem RR: Venous invasion may predict lymph node metastasis in early rectal cancer. Eur J Surg Oncol. 28:413–417. 2002. View Article : Google Scholar : PubMed/NCBI | |
Shimomura T, Ishiguro S, Konishi H, Wakabayashi N, Mitsufuji S, Kasugai T, Manou M and Kodama T: New indication for endoscopic treatment of colorectal carcinoma with submucosal invasion. J Gastroenterol Hepatol. 19:48–55. 2004. View Article : Google Scholar : PubMed/NCBI | |
Hahnloser D, Wolff BG, Larson DW, Ping J and Nivatvongs S: Immediate radical resection after local excision of rectal cancer: An oncologic compromise? Dis Colon Rectum. 48:429–437. 2005. View Article : Google Scholar : PubMed/NCBI | |
Kawamura YJ, Sakuragi M, Togashi K, Okada M, Nagai H and Konishi F: Distribution of lymph node metastasis in T1 sigmoid colon carcinoma: Should we ligate the inferior mesenteric artery? Scand J Gastroenterol. 40:858–861. 2005. View Article : Google Scholar : PubMed/NCBI | |
Kojima M, Shiokawa A, Ohike N, Ohta Y, Kato H, Iwaku K, Hayasi R and Morohoshi T: Clinical significance of nuclear morphometry at the invasive front of T1 colorectal cancer and relation to expression of VEGF-A and VEGF-C. Oncology. 68:230–238. 2005. View Article : Google Scholar : PubMed/NCBI | |
Wang HS, Liang WY, Lin TC, Chen WS, Jiang JK, Yang SH, Chang SC and Lin JK: Curative resection of T1 colorectal carcinoma: Risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum. 48:1182–1192. 2005. View Article : Google Scholar : PubMed/NCBI | |
Abe A, Fukui H, Fujii S, Fujita M, Mukawa K, Ichikawa K, Tomita S, Ono Y, Imai Y, Imura J, et al: Involvement of cyclooxygenase-2 and vascular endothelial growth factor in vascularization and lymph node metastasis of colorectal cancers with submucosal invasion. J Gastroenterol Hepatol. 22:1071–1077. 2007. View Article : Google Scholar : PubMed/NCBI | |
Yasuda K, Inomata M, Shiromizu A, Shiraishi N, Higashi H and Kitano S: Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection. Dis Colon Rectum. 50:1370–1376. 2007. View Article : Google Scholar : PubMed/NCBI | |
Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Yokoo T and Ishii T: Toho Study Group for Cancer Biological Behavior: Histopathologic determinants of regional lymph node metastasis in early colorectal cancer. Cancer. 112:924–933. 2008. View Article : Google Scholar : PubMed/NCBI | |
Kim JH, Cheon JH, Kim TI, Baik SH, Kim NK, Kim H and Kim WH: Effectiveness of radical surgery after incomplete endoscopic mucosal resection for early colorectal cancers: A clinical study investigating risk factors of residual cancer. Dig Dis Sci. 53:2941–2946. 2008. View Article : Google Scholar : PubMed/NCBI | |
Ishii M, Ota M, Saito S, Kinugasa Y, Akamoto S and Ito I: Lymphatic vessel invasion detected by monoclonal antibody D2-40 as a predictor of lymph node metastasis in T1 colorectal cancer. Int J Colorectal Dis. 24:1069–1074. 2009. View Article : Google Scholar : PubMed/NCBI | |
Akishima-Fukasawa Y, Ishikawa Y, Akasaka Y, Uzuki M, Inomata N, Yokoo T, Ishii R, Shimokawa R, Mukai K, Kiguchi H, et al: Histopathological predictors of regional lymph node metastasis at the invasive front in early colorectal cancer. Histopathology. 59:470–481. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kobayashi H, Higuchi T, Uetake H, Iida S, Ishikawa T, Ishiguro M and Sugihara K: Resection with en bloc removal of regional lymph node after endoscopic resection for T1 colorectal cancer. Ann Surg Oncol. 19:4161–4167. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kye BH, Jung JH, Kim HJ, Kang SG, Cho HM and Kim JG: Tumor budding as a risk factor of lymph node metastasis in submucosal invasive T1 colorectal carcinoma: A retrospective study. BMC Surg. 12:2012. View Article : Google Scholar : PubMed/NCBI | |
Nasu T, Oku Y, Takifuji K, Hotta T, Yokoyama S, Matsuda K, Tamura K, Ieda J, Yamamoto N, Takemura S, et al: Predicting lymph node metastasis in early colorectal cancer using the CITED1 expression. J Surg Res. 185:136–142. 2013. View Article : Google Scholar : PubMed/NCBI | |
Wada H, Shiozawa M, Sugano N, Morinaga S, Rino Y, Masuda M, Akaike M and Miyagi Y: Lymphatic invasion identified with D2-40 immunostaining as a risk factor of nodal metastasis in T1 colorectal cancer. Int J Clin Oncol. 18:1025–1031. 2013. View Article : Google Scholar : PubMed/NCBI | |
Nishida T, Egashira Y, Akutagawa H, Fujii M, Uchiyama K, Shibayama Y and Hirose Y: Predictors of lymph node metastasis in T1 colorectal carcinoma: An immunophenotypic analysis of 265 patients. Dis Colon Rectum. 57:905–915. 2014. View Article : Google Scholar : PubMed/NCBI | |
Ryu HS, Kim WH, Ahn S, Kim DW, Kang SB, Park HJ, Park YS, Lee CH and Lee HS: Combined morphologic and molecular classification for predicting lymph node metastasis in early-stage colorectal adenocarcinoma. Ann Surg Oncol. 21:1809–1816. 2014. View Article : Google Scholar : PubMed/NCBI | |
Kang J, Lee HW, Kim IK, Kim NK, Sohn S-K and Lee KY: Clinical implications of microsatellite instability in T1 colorectal cancer. Yonsei Med J. 56:175–181. 2015. View Article : Google Scholar : PubMed/NCBI | |
Kawachi H, Eishi Y, Ueno H, Nemoto T, Fujimori T, Iwashita A, Ajioka Y, Ochiai A, Ishiguro S, Shimoda T, et al: A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: A retrospective multicenter study. Mod Path. 28:872–879. 2015. View Article : Google Scholar | |
Macias-Garcia F, Celeiro-Muñoz C, Lesquereux-Martinez L, Gude-Sampedro F, Uribarri-Gonzalez L, Abdulkader I, Alvarez-Castro A and Dominguez-Muñoz JE: A clinical model for predicting lymph node metastasis in submucosal invasive (T1) colorectal cancer. Int J Colorectal Dis. 30:761–768. 2015. View Article : Google Scholar : PubMed/NCBI | |
Sohn DK, Chang HJ, Park JW, Choi DH, Han KS, Hong CW, Jung KH, Kim DY, Lim SB, Choi HS and Jeong SY: Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type. J Clin Pathol. 60:912–915. 2007. View Article : Google Scholar : PubMed/NCBI | |
Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K and Morimatsu M: An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer. 63:539–543. 1989. View Article : Google Scholar : PubMed/NCBI | |
Walgenbach-Bruenagel G, Tolba RH, Varnai AD, Bollmann M, Hirner A and Walgenbach KJ: Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40. Eur Surg Res. 38:438–444. 2006. View Article : Google Scholar : PubMed/NCBI | |
Kahn HJ and Marks A: A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest. 82:1255–1257. 2002. View Article : Google Scholar : PubMed/NCBI | |
Kahn HJ, Bailey D and Marks A: Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 15:434–440. 2002. View Article : Google Scholar : PubMed/NCBI | |
La Vecchia C and Franceschi S: Reproductive factors and colorectal cancer. Cancer Causes Control. 2:193–200. 1991. View Article : Google Scholar : PubMed/NCBI | |
Fernandez E, La Vecchia C, Balducci A, Chatenoud L, Franceschi S and Negri E: Oral contraceptives and colorectal cancer risk: A meta-analysis. Br J Cancer. 84:722–727. 2001. View Article : Google Scholar : PubMed/NCBI | |
Grodstein F, Newcomb PA and Stampfer MJ: Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis. Am J Med. 106:574–582. 1999. View Article : Google Scholar : PubMed/NCBI | |
Hendifar A, Yang D, Lenz F, Lurje G, Pohl A, Lenz C, Ning Y, Zhang W and Lenz HJ: Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res. 15:6391–6397. 2009. View Article : Google Scholar : PubMed/NCBI | |
Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, Thibodeau SN and Potter JD: Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res. 67:7534–7539. 2007. View Article : Google Scholar : PubMed/NCBI | |
Walter P, Green S, Greene G, Krust A, Bornert JM, Jeltsch JM, Staub A, Jensen E, Scrace G, Waterfield M, et al: Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci USA. 82:7889–7893. 1985. View Article : Google Scholar : PubMed/NCBI | |
Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S and Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA. 93:5925–5930. 1996. View Article : Google Scholar : PubMed/NCBI | |
Barone M, Scavo MP, Papagni S, Piscitelli D, Guido R, Di Lena M, Comelli MC and Di Leo A: ERβ expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis. Scand J Gastroenterol. 45:1320–1328. 2010. View Article : Google Scholar : PubMed/NCBI | |
Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G and Papavassiliou AG: Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer. 39:1251–1258. 2003. View Article : Google Scholar : PubMed/NCBI | |
Jassam N, Bell SM, Speirs V and Quirke P: Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep. 14:17–21. 2005.PubMed/NCBI | |
Nüssler NC, Reinbacher K, Shanny N, Schirmeier A, Glanemann M, Neuhaus P, Nussler AK and Kirschner M: Gender-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer. Gend Med. 5:209–217. 2008. View Article : Google Scholar : PubMed/NCBI | |
Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O and Rice LW: Selective loss of estrogen receptor beta in malignant human colon. Cancer Res. 60:245–248. 2000.PubMed/NCBI | |
Roger P, Sahla ME, Mäkelä S, Gustafsson JA, Baldet P and Rochefort H: Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res. 61:2537–2541. 2001.PubMed/NCBI | |
Shaw JA, Udokang K, Mosquera JM, Chauhan H, Jones JL and Walker RA: Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. J Pathol. 198:450–457. 2002. View Article : Google Scholar : PubMed/NCBI |